Literature DB >> 10906326

Unique structural and functional properties of the ATP-binding domain of atypical protein kinase C-iota.

M Spitaler1, A Villunger, H Grunicke, F Uberall.   

Abstract

Atypical protein kinase C-iota (aPKCiota) plays an important role in mitogenic signaling, actin cytoskeleton organization, and cell survival. Apart from the differences in the regulatory domain, the catalytic domain of aPKCiota differs considerably from other known kinases, because it contains a modification within the glycine-rich loop motif (GXGXXG) that is found in the nucleotide-binding fold of virtually all nucleotide-binding proteins including PKCs, Ras, adenylate kinase, and the mitochondrial F1-ATPase. We have used site-directed mutagenesis and kinetic analysis to investigate whether these sequence differences affect the nucleotide binding properties and catalytic activity of aPKCiota. When lysine 274, a residue essential for ATP binding and activity conserved in most protein kinases, was replaced by arginine (K274R mutant), aPKCiota retained its normal kinase activity. This is in sharp contrast to results published for any other PKC or even distantly related kinases like phosphoinositide 3-kinase gamma, where the same mutation completely abrogated the kinase activity. Furthermore, the sensitivity of aPKCiota for inhibition by GF109203X, a substance acting on the ATP-binding site, was not altered in the K274R mutant. In contrast, replacement of Lys-274 by tryptophan (K274W) completely abolished the kinase activity of PKCiota. In accordance with results obtained with other kinase-defective PKC mutants, in cultured cells aPKCiota-K274W acted in a dominant negative fashion on signal transduction pathways involving endogenous aPKCiota, whereas the effect of the catalytically active K274R mutant was identical to the wild type enzyme. In summary, aPKCiota differs from classical and novel PKCs also in the catalytic domain. This information could be of significant value for the development of specific inhibitors of aPKCiota as a key factor in central signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906326     DOI: 10.1074/jbc.M002742200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells.

Authors:  Flavia A Wald; Andrea S Oriolo; Anastasia Mashukova; Nevis L Fregien; Amber H Langshaw; Pedro J I Salas
Journal:  J Cell Sci       Date:  2008-02-12       Impact factor: 5.285

Review 2.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

Review 3.  The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

Authors:  Miguel Reina-Campos; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2019-08-29       Impact factor: 31.743

Review 4.  Metabolic functions of atypical protein kinase C: "good" and "bad" as defined by nutritional status.

Authors:  Robert V Farese; Mini P Sajan
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-08       Impact factor: 4.310

5.  Expression of the human atypical kinase ADCK3 rescues coenzyme Q biosynthesis and phosphorylation of Coq polypeptides in yeast coq8 mutants.

Authors:  Letian X Xie; Edward J Hsieh; Shota Watanabe; Christopher M Allan; Jia Y Chen; UyenPhuong C Tran; Catherine F Clarke
Journal:  Biochim Biophys Acta       Date:  2011-02-04

Review 6.  Inflammatory bowel disease reveals the kinase activity of KSR1.

Authors:  Richard Kolesnick; H Rosie Xing
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

7.  NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop.

Authors:  Jie Shen; Lijun Xu; Taofeek K Owonikoko; Shi-Yong Sun; Fadlo R Khuri; Walter J Curran; Xingming Deng
Journal:  Cancer Lett       Date:  2011-12-13       Impact factor: 8.679

8.  Protein kinases Fpk1p and Fpk2p are novel regulators of phospholipid asymmetry.

Authors:  Kenzi Nakano; Takaharu Yamamoto; Takuma Kishimoto; Takehiro Noji; Kazuma Tanaka
Journal:  Mol Biol Cell       Date:  2008-01-16       Impact factor: 4.138

9.  Protein kinase B (PknB) of Mycobacterium tuberculosis is essential for growth of the pathogen in vitro as well as for survival within the host.

Authors:  Yogesh Chawla; Sandeep Upadhyay; Shazia Khan; Sathya Narayanan Nagarajan; Francesca Forti; Vinay Kumar Nandicoori
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

Review 10.  Exploring the ATP-binding site of P2X receptors.

Authors:  Thierry Chataigneau; Damien Lemoine; Thomas Grutter
Journal:  Front Cell Neurosci       Date:  2013-12-30       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.